Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:07 PM
Ignite Modification Date: 2025-12-25 @ 12:21 PM
NCT ID: NCT02118961
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT02118961
Study Brief: Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
BK1301 Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301): 0.5 mL, subcutaneous injection None None 0 223 200 223 View
DT Toxoid Adsorbed Diphtheria-Tetanus Combined Toxoid (DT toxoid): 0.1 mL, subcutaneous injection None None 0 222 194 222 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site pain None General disorders MedDRA 17 View
Headache None Nervous system disorders MedDRA 17 View
Injection site erythema None General disorders MedDRA 17 View
Injection site induration None General disorders MedDRA 17 View
Injection site pruritus None General disorders MedDRA 17 View
Injection site swelling None General disorders MedDRA 17 View
Injection site warmth None General disorders MedDRA 17 View
Pyrexia None General disorders MedDRA 17 View
Nasopharyngitis None Infections and infestations MedDRA 17 View